Lv3
298 积分 2022-02-22 加入
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
2天前
已完结
成人甲状腺功能减退症诊治指南
29天前
已完结
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer
4个月前
已完结
Sintilimab Plus Chemotherapy for Unresectable Gastric or Gastroesophageal Junction Cancer
4个月前
已完结
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia
5个月前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
6个月前
已完结
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
6个月前
已完结
Targeted therapy in advanced BRAF -mutated colorectal cancer: systematic review and network meta-analysis
6个月前
已完结
Biology and Clinical Management of Non-V600 BRAF Alterations in NSCLC
6个月前
已完结
BRAF — a tumour-agnostic drug target with lineage-specific dependencies
6个月前
已完结
皖公网安备34019202002308
